Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CORCEPT THERAPEUTICS INC Director's Dealing 2012

Jun 15, 2012

30681_dirs_2012-06-15_8cb9b576-f278-416e-b23f-dd5b2a141166.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2012-06-13

Reporting Person: BAKER G LEONARD JR (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-06-13 Stock Option (Right To Buy) $4.0500 A 30000.0000 Acquired 2022-06-13 Common Stock (30000.0000) Direct

Footnotes

F1: The reporting person shares pecuniary interest in these shares with other individuals pursuant to a contractual relationship. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in these shares.

F2: Exercisable with respect to 8.3334% of the total option shares on each monthly anniversary of June 13, 2012, with the final vesting of all remaining shares to occur on or before the date of Corcept's 2013 Annual Meeting.